Novo Nordisk

USA — Novo Nordisk, a prominent pharmaceutical company, has recently taken legal action against compounding pharmacies, filing three lawsuits in Florida and one in Tennessee.…

USA —Novo Nordisk, the maker of weight-loss drug Wegovy, has filed lawsuits against medical spas and wellness clinics in the United States for selling products…

DENMARK —Novo Nordisk, a leading pharmaceutical company, announced on Tuesday that the launch of Wegovy (semaglutide) in Europe will face delays due to the company’s…

DENMARK —Danish pharmaceutical company, Novo Nordisk has announced a significant investment of 15.9 billion Danish crowns (approximately US$2.29 billion) to expand its production facility in…

USA — Danish pharmaceutical company, Novo Nordisk, has announced that it will limit the supply of starter doses of weight-loss medication Wegovy as the demand…

USA — Pharmaceutical company Eli Lilly has registered a phase 3b clinical trial on clinicaltrials.gov for its weight loss drug, Mounjaro. The study, known as…

DENMARK —Novo Nordisk, a global healthcare company specializing in diabetes care, has joined forces with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and…

INDIA – The Novo Nordisk Foundation has launched the Partnership for Education of health Professionals (PEP) to support the education of health professionals in India…

USA — Novo Nordisk’s Ozempic, a treatment for type 2 diabetes and off-label for weight loss, is no longer on the FDA’s drug shortage list…

UNITED KINGDOM — Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years due to…